BioStar Capital-Backed Amplitude Vascular Systems $835M Acquisition by Stryker Reflects Strength of Michigans Medtech Ecosystem
BioStar Capital, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of Amplitude Vascular Systems, Inc. (AVS), a medical technology company...